Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (repealed) (c. 2377)

[F1ANNEX III U.K. LIST OF PHARMACOLOGICALLY ACTIVE SUBSTANCES USED IN VETERINARY MEDICINAL PRODUCTS FOR WHICH PROVISIONAL MAXIMUM RESIDUE LIMITS HAVE BEEN FIXED

Textual Amendments

F1 Substituted by Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin.

2. Antiparasitic agents U.K.

2.1. Agents acting against endoparasites U.K.

[F22.1.1. Phenol derivatives including salicylanides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Oxyclozanide	Oxyclozanide	Bovine	20 μg/kg	Muscle	[F3Provisional MRLs expire on 1.7.2002]
			20 μg/kg	Fat
			500 μg/kg	Liver
			100 μg/kg	Kidney
			10 μg/kg	Milk
		Ovine	20 μg/kg	Muscle
			20 μg/kg	Fat
			500 μg/kg	Liver
			100 μg/kg	Kidney]

Textual Amendments

F3 Substituted by Commission Regulation (EC) No 2338/2000 of 20 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

Textual Amendments

F2 Inserted by Commission Regulation (EC) No 997/1999 of 11 May 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

2.1.2. Benzimidazoles and pro-benzimidazoles U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Albendazole sulphoxide	Sum of albendazole, albendazole sulphoxide, albendazole sulphone, and albendazole 2-amino sulphone, expressed as albendazole	Bovine, ovine	100 μg/kg	Milk	Provisional MRLs expire on 1 January 2000
		Bovine, ovine, pheasant	100 μg/kg	Muscle
			100 μg/kg	Fat
			1 000 μg/kg	Liver
			500 μg/kg	Kidney
[F4Mebendazole	Sum of mebendazole methyl (5-(1-hidroxy, 1-phenyl) methyl-1H-benzimidazol-2-yl) carbamate and (2-amino-1H-benzimidazol-5-yl) phenylmethanone, expressed as mebendazole equivalents	Ovine, caprine, equidae Not for use in animals from which milk is produced for human consumption	60 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			60 μg/kg	Fat
			400 μg/kg	Liver
			60 μg/kg	Kidney]
Netobimin	Sum of netobimin and albendazole and metabolites of albendazole measured as 2-amino- benzimidazole sulphone	Bovine, ovine, caprine	100 μg/kg	Muscle	Provisional MRLs expire on 31 July 1999
			100 μg/kg	Fat
			1 000 μg/kg	Liver
			500 μg/kg	Kidney
			100 μg/kg	Milk

Textual Amendments

F4 Inserted by Commission Regulation (EC) No 2728/1999 of 20 December 1999 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F22.1.3. Tetrahydropyrimides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Morantel	Sum of residues which may be hydrolysed to N-Methyl-1,3-propanediamine and expressed as morantel equivalents	Bovine, ovine	100 μg/kg	Muscle	[F5Provisional MRLs expire on 1.7.2003]
			100 μg/kg	Fat
			800 μg/kg	Liver
			200 μg/kg	Kidney
			100 μg/kg	Milk
		Porcine	100 μg/kg	Muscle
			100 μg/kg	Skin and fat
			800 μg/kg	Liver
			200 μg/kg	Kidney]

Textual Amendments

F5 Substituted by Commission Regulation (EC) No 1322/2001 of 29 June 2001 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F62.1.5. Piperazine derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Piperazine	Piperazine	Porcine	400 μg/kg	Muscle	[F7Provisional MRLs expire on 1.7.2003]
			800 μg/kg	Skin and fat
			2 000 μg/kg	Liver
			1 000 μg/kg	Kidney
		Chicken	2 000 μg/kg	Eggs]

Textual Amendments

F7 Substituted by Commission Regulation (EC) No 1478/2001 of 18 July 2001 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

Textual Amendments

F6 Inserted by Commission Regulation (EC) No 2593/1999 of 8 December 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F42.1.6. Salicylanilides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Rafoxanide	Rafoxanide	Bovine Not for use in animals from which milk is produced for human consumption	30 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			30 μg/kg	Fat
			10 μg/kg	Liver
			40 μg/kg	Kidney
		Ovine Not for use in animals from which milk is produced for human consumption	100 μg/kg	Muscle
			250 μg/kg	Fat
			150 μg/kg	Liver
			150 μg/kg	Kidney]

2.2. Agents acting against ectoparasites U.K.

2.2.1. Formamidines U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Amitraz	Sum of amitraz and all metabolites containing the 2,4-DMA moeity, expressed as amitraz	Bees	200 μg/kg	Honey	Provisional MRLs expire on 1 July 1999

2.2.2. Iminophenyl thiazolidine derivative U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cymiazole	Cymiazole	Bees	1 000 μg/kg	Honey	[F8Provisional MRLs expire on 1.7.2001]

Textual Amendments

F8 Substituted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

2.2.3. Pyretrin and pyrethroids U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
^a [F9Provisional MRLs expire on 1 July 2006 .]
Cyfluthrin	Cyfluthrin	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1 January 2001
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
				Further provisions in Council Directive 94/29/EC are to be observed ( OJ L 189, 23.7.1994, p. 67 )
[F10Alphacypermethrin	Cypermethrin (sum of isomers)	Bovine, ovine	20 μg/kg	Muscle	[F11Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed]
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	Milk [F12Further provisions in Council Directive 93/57/EC ( OJ L 211, 23.8.1992, p. 1 ) are to be observed]
		Chicken	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Eggs
[F11Cypermethrin	Cypermethrin (sum of isomers)	Bovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003 Further provisions in Directive 93/57/EC are to be observed
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
			20 μg/kg	Milk
	Cypermethrin (sum of isomers)	Ovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2003 Not for use in animals from which milk is produced for human consumption
			200 μg/kg	Fat
			20 μg/kg	Liver
			20 μg/kg	Kidney]
		Porcine	20 μg/kg	Muscle
			200 μg/kg	Skin + fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
		Chicken	50 μg/kg	Muscle
			50 μg/kg	Skin + fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Eggs
		Salmonidae	50 μg/kg	Muscle and skin in natural proportions	[F13Provisional MRLs expire on 1.7.2003] ]
[F14Deltamethrin	Deltamethrin	Bovine	10 μg/kg	Muscle	Provisional MRLs expire on 1 July 2001
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			20 μg/kg	Milk
		Ovine Not for use in animals from which milk is produced for human consumption	10 μg/kg	Muscle
			50 μg/kg	Fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
		Chicken	10 μg/kg	Muscle	[F15Provisional MRLs expire on 1.7.2003]
			50 μg/kg	Skin + fat
			10 μg/kg	Liver
			10 μg/kg	Kidney
			50 μg/kg	Eggs
[F16		Fin fish	10 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1.1.2002] ]
[F17Fenvalerate ^a	Fenvalerate (sum of RR, SS, RS and SR isomers)	Bovine	25 μg/kg	Muscle
			250 μg/kg	Fat
			25 μg/kg	Liver
			25 μg/kg	Kidney
			40 μg/kg	Milk]
[F18Permethrin	Permethrin (sum of isomers)	Chicken, porcine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2003
			500 μg/kg	Skin and fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
		Bovine, caprine	50 μg/kg	Muscle	Provisional MRLs expire on 1.1.2003
			500 μg/kg	Fat
			50 μg/kg	Liver
			50 μg/kg	Kidney
			50 μg/kg	Milk	Further provisions in Commission Directive 98/82/EC are to be observed ( OJ L 290, 29.10.1998, p. 25 )
		Chicken	50 μg/kg	Eggs	Provisional MRLs expire on 1.1.2003]

Textual Amendments

F9 Inserted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).

F10 Inserted by Commission Regulation (EC) No 954/1999 of 5 May 1999 amending Annex III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F11 Substituted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F12 Deleted by Commission Regulation (EC) No 869/2002 of 24 May 2002 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F13 Inserted by Commission Regulation (EC) No 77/2002 of 17 January 2002 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F14 Inserted by Commission Regulation (EC) No 1942/1999 of 10 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F15 Inserted by Commission Regulation (EC) No 1815/2001 of 14 September 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F16 Inserted by Commission Regulation (EC) No 1960/2000 of 15 September 2000 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F17 Substituted by Commission Regulation (EC) No 1875/2004 of 28 October 2004 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards sodium salicylate and fenvalerate (Text with EEA relevance).

F18 Substituted by Commission Regulation (EC) No 807/2001 of 25 April 2001 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

2.2.4. Organophosphates U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Azamethiphos	Azamethiphos	Salmonidae	100 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 June 1999
[F19Coumafos	Coumafos	Bees	100 μg/kg	Honey	Provisional MRLs expire on 1.7.2001]
[F20Phoxim	Phoxim	Porcine	20 μg/kg	Muscle	Provisional MRLs expire on 1 January 2001
			700 μg/kg	Skin and fat
			20 μg/kg	Liver
			20 μg/kg	Kidney
		[F21Ovine	50 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001 ; not for use in animals from which milk is produced for human consumption
			400 μg/kg	Fat
			50 μg/kg	Kidney]
		[F22Chicken	50 μg/kg	Muscle	Provisional MRLs expire on 1.7.2005 .
			550 μg/kg	Skin and fat
			25 μg/kg	Liver
			50 μg/kg	Kidney
			60 μg/kg	Eggs] ]
[F4Propetamphos	Sum of residues of propetamphos and desisopropyl-propetamphos	Ovine Not for use in animals from which milk is produced for human consumption	90 μg/kg	Fat	Provisional MRLs expire on 1.1.2001
[F4Propetamphos			90 μg/kg	Kidney]	Provisional MRLs expire on 1.1.2001

Textual Amendments

F19 Inserted by Commission Regulation (EC) No 1931/1999 of 9 September 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F20 Inserted by Commission Regulation (EC) No 2385/1999 of 10 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F21 Inserted by Commission Regulation (EC) No 2391/2000 of 27 October 2000 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

F22 Inserted by Commission Regulation (EC) No 2011/2003 of 14 November 2003 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

2.2.5. Acyl urea derivates U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Teflubenzuron	Teflubenzuron	Salmonidae	500 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1 July 1999
[F2Diflubenzuron	Diflubenzuron	Salmonidae	1 000 μg/kg	Muscle and skin in natural proportions	Provisional MRLs expire on 1.7.2000]

[F232.2.6. Pyrimidines derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Dicyclanil	Sum of dicyclanil and 2,4,6-triamino-pyrimidine-5-carbonitrile	Ovine	200 μg/kg	Muscle	Provisional MRLs expire on 1 July 2000 ; Not for use in animals from which milk is produced for human consumption
			50 μg/kg	Fat
			400 μg/kg	Liver
			400 μg/kg	Kidney]

Textual Amendments

F23 Inserted by Commission Regulation (EC) No 2393/1999 of 11 November 1999 amending Annexes I, II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

[F62.2.7. Triazine derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Cyromazine	Cyromazine	Ovine	300 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001 Not for use in animals from which milk is produced for human consumption
			300 μg/kg	Fat
			300 μg/kg	Liver
			300 μg/kg	Kidney]

2.3. Agents acting against endo- and ectoparasites U.K.

2.3.1. Avermectins U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
[F4Abamectin	Avermectin B1a	Ovine	20 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			50 μg/kg	Fat
			25 μg/kg	Liver
			20 μg/kg	Kidney
Doramectin	Doramectin	Deer, inclusing reindeer	20 μg/kg	Muscle	Provisional MRLs expire on 1.7.2001
			100 μg/kg	Fat
			50 μg/kg	Liver
			30 μg/kg	Kidney]
Moxidectin	Moxidectin	Equidae	50 μg/kg	Muscle	Provisional MRLs expire on 1 January 2000
			500 μg/kg	Fat
			100 μg/kg	Liver
			50 μg/kg	Kidney

[F242.4. Agents acting against protozoa U.K.

2.4.1. Carbanilides U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Imidocarb	Imidocarb	Bovine, ovine	300 μg/kg	Muscle	Provisonal MRLs expire on 1.1.2002
			50 μg/kg	Fat
			2 000 μg/kg	Liver
			1 500 μg/kg	Kidney
			50 μg/kg	Milk

[F22.4.2. Quinazolone derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
Halofuginone	Halofuginone	Bovine	10 μg/kg	Muscle	Provisional MRL's expire on 1.1.2001
			25 μg/kg	Fat
			30 μg/kg	Liver
			30 μg/kg	Kidney]

[F62.4.3. Triazinetrione derivatives U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRLs	Target tissues	Other provisions
^a [F25Provisional MRLs expire on 1 July 2006 . Not for use in animals from which milk is produced for human consumption.] ]
Toltrazuril	Toltrazuril sulfone	Porcine	100 μg/kg	Muscle	Provisional MRLs expire on 1.1.2001
			150 μg/kg	Skin and fat
			500 μg/kg	Liver
			250 μg/kg	Kidney
[F25Toltrazuril ^a	Toltrazuril sulfone	Bovine	100 μg/kg	Muscle
			150 μg/kg	Fat
			500 μg/kg	Liver
			250 μg/kg	Kidney]

Textual Amendments

F25 Inserted by Commission Regulation (EC) No 2232/2004 of 23 December 2004 amending Annexes I, II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards altrenogest, beclomethasone dipropionate, cloprostenol, r-cloprostenol, sorbitan sesquioleate and toltrazuril (Text with EEA relevance).

[F262.4.4. Other anti-protozoal agents U.K.

Pharmacologically active substance(s)	Marker residue	Animal species	MRL	Target tissues	Other provisions
Amprolium	Amprolium	Chicken, turkey	200 μg/kg	Muscle	Provisional MRLs expire on 1.1.2002
			200 μg/kg	Skin and fat
			200 μg/kg	Liver
			400 μg/kg	Kidney
			1 000 μg/kg	Eggs] ] ]

Textual Amendments

F26 Inserted by Commission Regulation (EC) No 1295/2000 of 20 June 2000 amending Annexes II and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).

Textual Amendments

F24 Inserted by Commission Regulation (EC) No 953/1999 of 5 May 1999 amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance).